This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Harvard College, The Broad Institute, Inc., Massachusetts Institute of Technology. Active years: 2025.
Company Filing History:
3 out of 3,071 
3 out of 482 
2 out of 8,576 
Years Active: 2025
Title: Catherine Amanda Freije: Innovator in CRISPR Technology
Introduction
Catherine Amanda Freije is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of CRISPR-based diagnostic and therapeutic systems. With a total of 3 patents, her work is at the forefront of innovative solutions for viral detection and treatment.
Latest Patents
Freije's latest patents include groundbreaking inventions such as the "CRISPR Effector System Based Diagnostics for Hemorrhagic Fever Detection" and a novel "CRISPR System Based Antiviral Therapy." The latter offers a new approach for highly multiplexed, programmable antiviral therapies that directly target viral RNA. This technology can be flexibly adapted to target novel viruses or emerging outbreak pathogens. Class 2, type VI CRISPR system-based therapies can be used in combination with existing antiviral compounds, enhancing their efficacy and preventing the evolution of drug resistance mutations. If a virus evolves resistance to a specific guide RNA sequence, it is straightforward to switch to a different guide RNA sequence or design a new guide sequence to target the new mutation. Such strategies are crucial in preventing the widespread development of resistance to these innovative therapies.
Career Highlights
Freije has worked with prestigious institutions such as Harvard College and the Broad Institute, Inc. Her research and inventions have positioned her as a leader in the field of CRISPR technology, contributing to advancements that have the potential to revolutionize how we approach viral infections.
Collaborations
Throughout her career, Freije has collaborated with notable scientists, including Pardis Sabeti and Cameron Myhrvold. These partnerships have further enriched her research and expanded the impact of her innovations.
Conclusion
Catherine Amanda Freije is a trailblazer in the realm of CRISPR technology, with her inventions paving the way for new diagnostic and therapeutic strategies against viral diseases. Her work exemplifies the power of innovation in addressing global health challenges.